Skip to main navigation
Skip to search
Skip to main content
Maastricht University Home
Support & FAQ
Home
Researchers
Publications
Activities
Press/Media
Prizes
Organisations
Dataset/Software
Projects
Search by expertise, name or affiliation
Qi Luo
PhD
,
Faculty of Health, Medicine and Life Sciences
,
Biochemie
Carim - Cell biochemistry of thrombosis and haemostasis
2022
2026
Research activity per year
Overview
Fingerprint
Network
Publications
(5)
Similar Profiles
(12)
Fingerprint
Dive into the research topics where Qi Luo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Thrombosis
75%
Maastricht
75%
Consensus Conference
75%
Position Paper
75%
Blood Coagulation
75%
Myocardial Infarction
75%
Macrophages
75%
Coagulation Factor VII
75%
Adverse Cardiac Remodeling
75%
Adhesion Pattern
75%
Collagen
75%
Platelet Adhesion
75%
Platelet Collagen Receptor
75%
Collagen Substrate
75%
Tissue Factor
37%
Soluble Collagen
34%
Coagulopathy
32%
FVIIa
30%
Myeloid Cells
30%
Glycoprotein VI
28%
Signaling Complex
22%
Integrin 1
22%
Cardiac Dysfunction
22%
Bleeding Risk
21%
Bleeding
21%
Rat Tail
17%
Collagen Receptor
17%
P-selectin Expression
17%
Platelets
17%
Macrophage Reprogramming
15%
Medicine and Dentistry
Blood Clotting
100%
Thrombosis
75%
Factor VII
75%
Heart Ventricle Remodeling
75%
Myocardial Infarction
75%
Macrophage
75%
Collagen Receptor
75%
Thrombocyte Adhesion
75%
Platelet
75%
Glycoprotein VI
62%
Thromboplastin
37%
Metahexamide
37%
PADGEM Protein
37%
Tail
37%
Myeloid Cell
30%
Coagulopathy
28%
Bleeding
28%
Thrombocyte Activation
24%
Thrombus
24%
Collagen Type 1
24%
Integrin
22%
Antiplatelet
21%
Monoclonal Antibody
20%
Receptor
20%
Cancer Growth Factor
15%
Ligation
15%
Ischemic Heart Disease
15%
Mitogen-Activated Protein Kinase
15%
Fibrinogen
15%
Hematology
12%
INIS
receptors
97%
conferences
75%
blood coagulation
75%
thrombosis
75%
myocardial infarction
75%
macrophages
75%
collagen
75%
adhesion
75%
substrates
75%
mice
45%
tissues
37%
proteins
31%
control
24%
inflammation
22%
organs
18%
risks
18%
comparative evaluations
17%
genetics
16%
anticoagulants
16%
surfaces
15%
mitogens
15%
heart disease
15%
growth factors
15%
monocytes
15%
ischemia
15%
fibrosis
15%
kinases
15%
glycoproteins
12%
testing
11%
monoclonal antibodies
10%